Lee Quo Wei Professor of Neurology The Chinese University of Hong Kong, Hong Kong

Thomas is a Medical Graduate from The Chinese University of Hong Kong (CUHK) in 1995, trained locally in general medicine and neurology. He is now the Head of Division of Neurology, CUHK, awarded the Lee Quo-Wei Professorship of Neurology. He also serves as an Assistant Dean (Education) for Faculty of Medicine, CUHK. Thomas Aims to translate science into health service. He is the first interventional neurologist in Hong Kong, and a Neuro-sonologist certified by American Society of Neuroimaging. He is also the national coordinator for Safe Implementation of Treatment in Stroke (SITS), council member in National Endovascular Treatment for Storke Committee, and Stroke Prevention and Risk Factor Control Committee, China, and the President of Hong Kong Neurological Society. His research interests in intracranial atherosclerosis, stroke imaging and cerebral re-vascularisation therapy have generated numerous competitive grants as principal investigators, overseas collaborations and private donations. He has published as the first or corresponding author in high-impact specialty journals including Annals of Neurology, Neurology, Stroke, JAMA Neurology, and Journal of Neurology, Neurosurgery and Psychiatry (JNNP). He is also reviewers, editorial board members and assistant/ associate editors of well-known international journals in stroke medicine and neurology. Thomas's achievement in clinical service, teaching and research are phenomenal. A few important examples are CUHK Faculty of Medicine Best Teacher Award 2019, Outstanding Team Award 2019 as team leader of the Prince of Wales Hospital's acute stroke unit, Director of the Kwok Tak Seng Centre for Stroke Research and Intervention, Director of SHKP Kwok Brain Health Research Centre, collaborating with her sister centre, the Henry and Allison McCance Centre for Brain Health of MGH of Boston, doing impactful population based work, and Programme Co-director of a master programme in Stroke and Clinical Neurosciences, a popular course for health-care professionals.

Danny is a Consultant Neurosurgeon, Clinical Associate Professor (Honorary) and Head of Division of Neurosurgery, Department of Surgery at Prince of Wales Hospital (PWH)/ The Chinese University of Hong Kong (CUHK). Danny is a CUHK medical graduate in 1995. He completed his specialist training in Neurosurgery in 2004 and was awarded the Douglas Miller Gold Medal for distinction in Neurosurgery by The College of Surgeons of Hong Kong and The Royal College of Surgeons, Edinburgh. He received his overseas training for Neuro-Oncology at MD Anderson Cancer Centre under the mentorship of Professor Alfred Yung in 2007. Danny is also the Co-Director of CUHK Otto Lien Da Wong Brain Tumour Centre and the Chairman of Coordinating Committee for Neurosurgery of Hong Kong Hospital Authority for Neurosurgery leading the neurosurgical services in Hong Kong. His multi-disciplinary work in neuro-oncology and functional neurosurgery has been recognised locally and internationally with the establishment of the CUHK Otto Wong Brain Tumour Centre, the combined neuro-oncology clinic, the combined movement disorder clinic and the Deep Brain Stimulation program. In recent years, his collaborations have extended to medical engineering on stereotactic neuro-robots, novel cellular imaging techniques and Al precision therapeutics. His team was awarded the best paper award in Medical Robotics and the best Conference paper at the IEEE international conference on Robotics and Automation-lCRA 2018 and a Bronze medal at the 2022 special edition of the Geneva International Exhibition of Inventions. More recently, Dr Chan was awarded the 2022 Bank of China (Hong Kong) Science and Technology Innovation (Artificial Intelligence and Robotics) prize on a collaborative project of a flexible robotised neuro-endoscopy with Professor Hongbin Liu of Centre for Artificial Intelligence and Robotics (CAIR) Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences.

Chair Professor The Chinese University of Hong Kong (CUHK), Hong Kong

H.K. is Chair Professor at CUHK. His interests are in the molecular pathology of brain tumours, both adult and paediatric. H.K. is both a neuropathologist and general pathologist. He is an Associate Editor of Laboratory Investigation and an Associate Editor of Neuro-Oncology Advances, and is also on the Editorial Boards of Acta Neuropathologica, Brain Pathology, Glioma, Neuropathology and Applied Neurobiology, Clinical Neuropathology, and Pathology. He was a member of the Consensus Group of the 2007 and 2016 WHO classifications of the brain tumours. He is also a member of cIMPACT-NOW, which is an extension of The WHO classification. And for the WHO 2021 Classification, he is one of the only 10 neuropathologists from around the world to have been selected for the Consensus Group. H.K. was part of the team who received The 2nd Tier Award of The National Science and Technology Award of China in 2010 and the First Tier Science and Technology Award of Shanghai in 2019. He received the International Academy of Pathology Gold Medal twice in 2006 and 2017, and the HMRF Research Award of the Hong Kong Department of Health in 2021.

Timmy is a Consultant Anaesthetist and Pain Specialist at the Department of Anaesthesia, Pain and Periopertaive Medicine, Queen Mary Hospital, Hong Kong. He is the Clinical Team Head of Pain Management Team. He is a Fellow of the Interventional Pain Practice (FIPP), The World Institute of Pain. He is the winner of the Hassenbusch Prize of FIPP in 2013. Dr. Chan is the Charmian of the Multidisciplinary Pain Management Committee in the Hospital Authority. He is the Charmain of the Board of Pain Medicine of The Hong Kong College of Anaesthesiologists. Timmy has wide-ranging clinical interests, including cancer pain management, interventional pain management for non-cancer pain especially neuromodulation, and acute post-operative pain management after major joints arthroplasty.

Professor Chan is a cancer biologist. He obtained his Ph.D. degree in Molecular Biology from the Institute of Cancer Research at the Royal Marsden Hospital, University of London (1989). He was a Fogarty International Fellow at the National Cancer Institute of the United States National Institutes of Health (1989-1994), and Faculty Members at the Mount Sinai School of Medicine (1994-2008) and the Medical College of Wisconsin (2008-2012) before joining the School of Biomedical Sciences of the Chinese University of Hong Kong (CUHK). Professor Chan is currently a member of the Cancer Biology & Experimental Therapeutics Thematic Research Program. He serves on multiple governmental granting agencies and has published more than 80 peer-reviewed papers with some in high impact journals such as Science, Nature Genetics, Cancer Cell, PNAS, Blood, and Nature Neuroscience. His laboratory focuses on various cancer cell signaling pathways in the initiation and progression of human cancer. His research involves understanding the regulatory mechanisms of the PTEN tumor suppressor in brain cancer and neurodevelopmental disorders.

Denis is a 1981 medical graduate of Angers University in France. He is Head of the Department of Anesthesiology and Pain Medicine of Institut de Cancerologie de l�Ouest (ICO) where he has been practicing for over a 20 years� period. Denis is one of the renowned experts on intrathecal analgesia. His work in intrathecal analgesia for intractable pain and cancer pain has been adopted world-wide. He recently has been elected winner of the Axel Kahn Pain and Cancer Prize (2023).

Hongbin is the Executive Director of Centre for AI and Robotics (CAIR), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, a Professor at Chinese Academy of Sciences, Institute of Automation (CASIA), and Group Director for intelligent minimally invasive technologies of CASIA. Prior to joining the Chinese Academy of Sciences, he served as a Reader in Medical Robotics at King�s College London (KCL), UK and Director of the Haptics Mechatronics and Medical Robotics (HaMMeR) Laboratory. Hongbin has been focusing on research and development of fully sensorised minimally invasive surgical robotic system with self-evolving intelligence for safer and more effective diagnosis and treatment. Research directions include haptic and proprioceptive sensing, real-time surgical simulation, soft/flexible robot actuation, and multimodality-based navigation and control. His research has led to the clinical translation of a series of flexible surgical robotic systems for applications such as minimally invasive neurosurgery, bronchoscopy as well as vascular surgery.

Anthony is a Paediatric Oncologist. He currently is a Clinical Assistant Professor at the Department of Paediatrics and Adolescent Medical, the University of Hong Kong (HKU). He received his medical degree with distinction in Paediatrics, Obstetrics and Gynecology from HKU (2009) and Master of Medical Sciences in Genetic Counselling (2013). After he completed his specialist training in Paediatrics (2016), he spent 3 years and 6 months in St. Jude Children�s Research Hospital as a Neuro-oncology Fellow under the supervision of Dr Amar Gajjar (clinical) and Dr Paul Northcott (research). His research interests include molecular profiling of brain tumours and methods in liquid biopsy.

Gabriel graduated in 2007 from Manipal University College Malaysia. He received his training in Neurosurgery at Prince of Wales Hospital in Hong Kong, and National University Hospital and Khoo Teck Puat Hospital in Singapore. He obtained the fellowships from European Board of Neurosurgical Surgery (2017) and Royal College of Surgeons of Ireland (2018) and acquired a Diploma in Pain Intervention from University Montpellier, France in 2020. Gabriel is currently a Resident at Department of Neurosurgery of PWH and Honorary Clinical Assistant Professor at The Chinese University of Hong Kong. His clinical interests are Skull Base Surgery, Neurovascular Surgery, Spinal Surgery and Pain Intervention.

Mr Marcus is a Consultant Neurosurgeon at the National Hospital for Neurology and Neurosurgery, and Honorary Associate Professor at the University College London (UCL) Queen Square Institute of Neurology. He is a Cambridge graduate in Neuroscience (2003) and Medicine (2006). He completed his specialist training in Neurosurgery at Imperial College London, University of Calgary and Hirslanden. Mr Marcus specialises in treating patients with pituitary adenoma, and related skull base tumours. In 2020, he cofounded the British Neuro-endoscopy Society to drive the advancement of endoscopic techniques and led the largest prospective study of patients undergoing pituitary surgery worldwide, including 866 patients across 30 centres in the United Kingdom and Ireland. Mr Marcus has a research interest in technologies such as augmented reality, robotics, and artificial intelligence. He obtained his PhD from Imperial College London. His work has attracted over �2.5 million in research funding, resulted in over 150 peer-reviewed publications. He serves as Deputy Director of the Wellcome / EPSRC Centre for Interventional and Surgical Sciences (WEISS) and the regional Lead for Neurosurgery and Brain Cancer at the National Institute for Health Research Clinical Research Network.

Paul is a leading paediatric brain tumour genome scientist particularly in medulloblastoma. Currently he is holding a post as Full Member (equivalent to Full Professor) at the Department of Developmental Neurobiology of St. Jude Children�s Research Hospital. He moved on as a biology graduate of Palm Beach Atlantic University, Florida (2000) to pursue a master degree in medical genetic at McMaster University (2004). In 2004-2015 during his Ph.D. study at the University of Toronto and postdoctoral fellowship at the Hospital for Sick Children and Cancer Research Center (DKFZ), Heidelberg, medulloblastoma's genetic features, origin of cells in the hindbrain were parts of his works. From being a Ph.D. student, to a senior researcher and now a faculty member at St Jude (since 2015), Paul continues to contribute to our understanding of the biological and clinical heterogeneity of this childhood brain cancer, and its management such as detecting residual and early predicting progression and recurrent disease, to further improve diagnosis and classification of medulloblastoma for effective treatment. He is the recipient of several prestigious accolades for his work and contribution in paediatric cancer including the Pew-Stewart Scholar for Cancer Research Award (2016), Sontag Foundation Distinguished Scientist Award (2016), Inaugural AACR NextGen Grant for Transformative Research (2016) and the St. Baldrick�s Robert J. Arceci Innovation Award (2020).

Peter is a medical graduate of Shanghai Medical College and completed the residency training in neurosurgery at Huashan under the direct supervision of Academician Zhou Liang-fu. His in-depth study of brain tumour pathology research with Professor H.K. Ng of The Chinese University of Hong Kong has started him on a productive path of glioma work. He has carried out Radiomics study in glioma with developing several noninvasive methods predicting molecular biomarkers based on MRI images. He has also worked on advanced biomaterials compatible for neurosurgical implant medical devices. His clinical and research interests focus on minimally invasive keyhole surgery and comprehensive treatment of brain tumours, particularly gliomas. His hard work has resulted in high citation publications in Radiology, Cell Research and Nature Communications. His research is well supported by the Shanghai City Government, National Natural Science Foundation of China (NSFC) and the Chinese 973 Projects.

David completed his BSc (Pathobiology), MSc (Molecular Biology), and PhD (Genomics) programmes at the University of Toronto, and he undertook postdoctoral training in the Department of Data Science at Dana-Farber Cancer Institute, with cross-appointments in the Department of Biostatistics at Harvard T.H. School of Public Health and in the Cancer Program at the Broad Institute. He also did a postdoctoral fellowship in Systems Biology at MD Anderson Cancer Institute. Prior to joining HKU, David was a Research Assistant Professor in the School of Biomedical Informatics at the University of Texas Health Science Center, while serving as Co-Director of the Data Science and Informatics Core for Cancer Research. In his past research, Peter characterized the genomics of pediatric brain tumors in order to identify molecular subtypes of cancer, cancer driver genes, aberrant molecular pathways, and prognostic biomarkers. His current research focuses on developing tailored statistical models and computational algorithms in order to derive insights from integrative genomics, high-throughput sequencing, and electronic health record data. He is particularly interested in developing statistical models that are informed by scientific knowledge and accelerated by deep learning algorithms. In this way, this framework can benefit from the rigor and interpretability of statistical models as well as the flexibility and efficiency of machine learning techniques.

Professor Son is a medical graduate and PhD graduate of the College of Medicine, The Catholic University of Korea. He joined St. Mary Hospital, The Catholic University of Korea as neurosurgical resident in 1990 and has been a faculty member in academic neurosurgery since 1997 and become Professor in 2012. Professor Son received his overseas training in functional neurosurgery at University of Toronto, under the supervision of Professor Andres W. Lozano. His clinical and research interests are stereotactic and functional neurosurgery for movement disorder (Parkinson�s disease, Tremor, and hemifacial spasm) and pain surgery (spinal cord injury pain, post-traumatic neuralgia, trigeminal neuralgia, occipital neuralgia and postherpetic neuralgia), epilepsy surgery (temporal lobe epilepsy, vagal nerve stimulation and deep brain stimulation) and neuromodulation for psychiatric disorder and memory impairment.

At the age of 17 years, Stefan was already a self-taught computer programmer and wrote a book on 3D Graphics which turned into a bestseller in its category. In the first year of his undergraduate study of Computer Programming and the Theory of Medical Technology at Technical University of Munich (1989), he soon established the Brainlab GmbH in the field of the software application of Neuronavigation and Radiotherapy. For over 30 years, Stefan has been the leader of the medical technology in navigation, fractionated radiotherapy, intra-operative imaging (both CT, MRI ultrasonography and DSA), robotics and the wise operating suite. He has been awarded numerous prizes, just to name a few: The Bavarian Innovation Award 2000, The World Entrepreneur of the year 2002, The German Federal President�s Award for Innovation and Technology 2022.

Padma Harilela Associate Professor of Life Science Hong Kong University of Science & Technology (HKUST), Hong Kong

Jiguang is an endowed Associate Professor in Division of Life Science and Department of Chemical and Biological Engineering of HKUST. He received his PhD degree in applied mathematics from Academy of Mathematics and Systems Science, Chinese Academy of Sciences (CAS), and won the Special Prize of President Scholarship and Excellent PhD thesis Award of CAS in 2011. Between 2011 and 2015, he was a Postdoctoral Research Scientist in Department of Biomedical Informatics at Columbia University. From 2015, he was named as the Precision Medicine Fellow and promoted to an Associate Research Scientist. Jiguang established the Wang Genomics Laboratory at HKUST in 2016, focusing on the application of data science technology in brain cancer genomics and medicine. He won the Excellent Young Scientist Award of NSFC (2019), School of Engineering Young Investigator Research Award (2019), School of Science Research Award (2021), and the Zhong Nanshan Youth Science and Technology Innovation Award (2021). His research interests are focusing on discovering and elucidating functional genomic alterations in complex human diseases, such as intracranial cancers and vascular malformations, by developing and/or applying computational methods based on multi-omics integration, statistics, and machine learning, aiming to bridge the gaps among data, bench, and bedside.

Professor of Neurology Heidelberg University, Germany

Professor Wick studied medicine at the University of Bonn, the University of Munster, Harvard Medical School and King's College London, and obtained a M.D. with distinction from the University of Bonn (1998). He did his residency training and research fellowship in Neurology at the University of Tubingen (1998-2003), Germany. He was Vice Chairman of Department of Neurology there before joining the University of Heidelberg (since 2007). Professor Wick is currently Professor of Neurology and Chairman of Department of Neurology subspecialising in Neuro-oncology at Heidelberg University Hospital, Heidelberg University. He is also the Head of Clinical Cooperation Unit Neuro-oncology of German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ). Professor Wick is an all-rounder: clinician, clinical teacher, clinical scientist and trialist, leading a team doing biology and experimental therapy for malignant brain tumours. He was the Past President of the European Society of Neuro-oncology (EANO, 2016-8). Since 2019, Professor Wick has been named �Highly Cited Researcher� by Clarivate Analytics. The honour is given to researchers who have demonstrated significant and broad influence in their fields of study, reflected in the publication of multiple papers which ranked in the top 1% by citations during the last decade. He has been accepted as a member of the German Academy of Sciences (Leopoldina) since 2020, and currently Chair of the German Council of Science and Humanities whose Medical Committee he has headed since 2022.

Tai-tong is currently Professor and Chief of Division of Paediatric Neurosurgery at Taipei Medical University Hospital. He was Chief of Division of Paediatric Neurosurgery, Neurological Institute, Taipei Veterans General Hospital (VGH) and Chief of Division of Neurosurgery at Cheng Hsin General Hospital. He received his medical degree at National Defense Medical University, Taipei (1973), general and neurosurgical training at Taipei VGH (1973-1978). He had been clinical and research fellow at SickKids, Toronto from 1980-1981. Tai-tong�s clinical interest is paediatric neurosurgery, in particular the aspects of paediatric brain and spinal tumours, paediatric epilepsy surgery, cerebral vascular diseases in children especially Moyamoya disease and vascular reconstruction surgery, spina bifida and tethered cord release. Research interests are medical informatics, 3D imaging/ virtual reality for Neurosurgery and Neuro-Oncology.

Peter is a 2004 medical graduate of The University of Hong Kong where he has obtained a Master degree in Medical Science (2010). He received the First Prize of Research of the Year Award from The College of Surgeons of Hong Kong and the First Prize of Higher Surgical Trainee Paper Presentation from the Hong Kong Neurosurgery Society during his Neurosurgical Training. He was qualified as Specialist Neurosurgeon in 2013. He subsequently matures in different areas: (1) neuro-oncology, (2) Honorary Secretary of the Specialty Board in Neurosurgery, an elected member, and (3) prolific writer in brain tumours and emergency neurosurgery. Peter is currently Consultant at Department of Neurosurgery, Prince of Wales Hospital, and Honorary Secretary of The College of Surgeons of Hong Kong and the Immediate Past President of The Hong Kong of Neuro-oncology Society.

Cindy is an Assistant Professor at Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong. Her research focuses are on stroke and intracranial atherosclerotic disease (ICAD). In the past few years, she has been utilizing multimodal neuroimaging and computational methods to study cerebral hemodynamics and plaque characteristics in ICAD and its clinical implications, using a cross-disciplinary approach. She also works on the efficacy and safety of medical and interventional treatment regimens in ischemic stroke, and investigates mechanisms of collateral circulation recruitment and its prognostic values in stroke patients. In these research areas, she has close collaboration with University of Oxford, University of California Los Angeles, Beijing Tiantan Hospital of Capital Medical University, and Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences. Cindy has been funded by the Research Grants Council of Hong Kong, the Health and Medical Research Fund, National Natural Science Foundation of China, China Association for Science and Technology, World Heart Federation, and the Lee Hysan Postdoctoral Fellowship in Clinical Neurosciences. Since 2013, she has published more than 60 peer-reviewed articles in international academic journals, including Circulation, Annals Neurology, Neurology, J Neurol Neurosurg Psychiatry, Stroke, with an h-index of 18. She is an Associate Editor of Stroke and Vascular Neurology (official journal of Chinese Stroke Association), and serves on the Editorial Board of Stroke (official journal of American Heart Association) and International Journal of Stroke (official journal of World Stroke Organization).

Kim is an Assistant Professor in the School of Life Sciences, CUHK. She received her graduate training in cancer biology at the University of Hong Kong (HKU), postdoctoral training at Cornell University, followed by a research assistant professorship training at Hong Kong University of Science and Technology (HKUST). Kim was a recipient of multiple international fellowships, including the Alzheimer�s Association Research Fellowship (2017-2021), the World Economic Forum Global Future Council Fellowship (2016-2019) and the Excellent Young Scientist Fund from National Natural Science Foundation of China (NSFC) in 2020. Her research focuses on studying mechanisms underlying pathological brain aging and related neurodegenerative disorders. Her current projects aim at delineating how the body metabolic status affects the brain central metabolism, leading to elevated risks of dementia and Alzheimer�s disease.

Linda obtained her bachelor's degree with full scholarship at the Chinese University of Hong Kong (CHUK) and received her Ph.D. degree from the School of Biomedical Sciences (SBS) at CUHK. She pursued postdoc training at Baylor College of Medicine (BCM) in the United States. Subsequently, she was selected into the highly competitive American Board of Medical Genetics and Genomic (ABMGG) fellowship program at BCM. Graduating from the three-year fellowship training, she was certified in both clinical molecular genetics and cytogenetics by ABMGG. In late 2019, she returned to SBS as an independent investigator. Her lab focuses on exploring the causes and clinical consequences of genetic diseases. She has published over 40 papers in high impact journals including American Journal of Human Genetics, PLoS Genetics, Human Molecular Genetics, and npj Genomic Medicine (>2,000 citations as in Jul 2023, h-index 24, i10-index 32). She received several international awards, including the 13th International Congress of Human Genetics Travel Award, finalist and semi-finalist of ASHG / Charles J. Epstein Trainee Award for Excellence in Human Genetics Research, and three times Outstanding Research Award from the Association of Chinese Geneticists in America.

Jacque obtained his Bachelor of Science in Biochemistry from the University of Sydney with first class honours and university medal, and pursed his PhD in Biochemistry at The Hong Kong University of Science and Technology. Jacque received post-doctoral training at the Picower Institute for Learning and Memory, Massachusetts Institute of Technology (MIT). During his postgraduate study and postdoctoral training, he received a number of awards including the Croucher Studentship, the Sir Edward Youde Memorial fellowship, the International Brain Research Organization (IBRO) Rita Levi-Montalcini Research fellowship, and Human Frontier Science Program (HFSP) Long-Term fellowship. Recently, he has received the Aspirational Neuroscience Prize, RGC early career award, and NARSAD Young Investigator Award. Jacque has devoted his research to investigate the mechanisms of synaptic plasticity, and will continue to expand his research focus on how such mechanistic defects result in autism-related disorders through the use of multidisciplinary approaches. The foundation of his research builds on bridging the gaps between disciplines, particularly in molecular and system neuroscience, and also the gap between neurobiological research and problems in human medicine. His long-term goal is to apply multidisciplinary cutting-edge neurotechnology to probe brain function in health and disease. His work has been published in a number of peer-reviewed journals including Science, Nature Neuroscience, Nature Review Neuroscience, Molecular Psychiatry, and the Journal of Neuroscience.

David is a Professor at Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology. He obtained his Ph.D. degree in Materials from University of California, Santa Barbara. He was one of the key persons in the development of the theoretical foundation governing the nano and meso-scale elastic behavior and the smart contact lens with ocular decision analytics. He developed minimally invasive endoluminal radio frequency (RF) thrombectomy with the late Dr John KWOK, a pioneer neurosurgeon and neuro-interventionalist in Hong Kong, to treat blocked vessels in the brain. David is coordinating the activities of clinical specialists, AI modellers, and data analytic miners in the Hephaestus Project. The project aims to bring clarity, order, and precision analytics to the early detection and diagnosis of non-communicable diseases (NCDs).

Raymond is a Biomedical Engineer. He received his PhD in Bioengineering from the University of Strathclyde, Glasgow, UK in 1999. Raymond currently is a Professor and the Chairman of Department of Biomedical Engineering, The Chinese University of Hong Kong. He is among the world�s top 2% most-cited scientists in their main disciplines for career-long citation impact in 2020. His research interests include Rehabilitation Robotics (e.g. Hand of Hope), Brain-Computer Control Interface (BCI), Neural Engineering, Functional Electrical Stimulation (FES) and Cognitive Assessment Software. Projects have been funded by Innovation and Technology Fund and UGC CERG/GRF as principal investigator. His research, innovation and service have received Awardee of the 2013 Ten Outstanding Young Persons (Hong Kong); the Grand Prix Award (the highest honor) of the International Exhibition of Inventions of Geneva 2012; Winner Award(e-Health) (the highest honor) in the Asia Pacific ICT Award 2012; and HKIE innovation awards for young members (2008), gold awards in international invention exhibitions (2004, 2007, 2010, 2015, 2016).

Ben is currently an Assistant Professor at the College of Chemistry and Environmental Engineering of Shenzhen University. He received his bachelor and master�s degree from Wuhan Institute of Technology and Hubei University respectively. He further pursued a Ph.D. degree at the Department of Biomedical Engineering, The Chinese University of Hong Kong (CUHK), followed by a postdoctoral fellowship at Department of Mechanical and Automation Engineering, CUHK. He joined Shenzhen University in December 2019. He published more than 20 papers in the fields of microrobotics and surface science with a total citation more than 3200. His current research interests are focused on surface functionalization, magnetic nanoparticles, and bioinspired soft robots for remote actuation and targeted delivery.

Choh-Ming Li Professor of Psychiatry The Chinese University of Hong Kong, Hong Kong

Professor Wing is currently the Chairman of the Department of Psychiatry of the Faculty of Medicine of the Chinese University of Hong Kong (CUHK). He is also the Director of the Li Chiu Kong Family Sleep Assessment Unit of CUHK. Professor Wing was awarded the distinguished national award for Sleep Medicine Scientific Technological Advance in China by the Chinese Medical Doctor Association at 2010 and distinguished contributions to the development of sleep medicine and sleep research by Chinese Sleep Research Society at 2016. Professor Wing has diverse research interest in sleep and circadian medicine, psychiatric disorders, neuropsychiatry, and transcultural psychopharmacology. He and his research group has established the first local epidemiological data of various sleep disorders including sleep deprivation, insomnia, narcolepsy, and parasomnia. In particular, the group has studied interaction of sleep and circadian propensity with psychiatric disorders. Professor Wing has active contribution to the scientific communities, including his leadership role in the Hong Kong Society of Sleep Medicine (ex-President, HKSSM) and Asian Sleep Society of Sleep Medicine (ASSM, Vice-president). He serves as Associate Editor in the journal �Behavioral Sleep Medicine�.

Hanna obtained her Ph.D. degree in Psychiatry from The Chinese University of Hong Kong in 2014. In 2023, she joined Department of Psychiatry, CUHK in 2023 as Assistant Professor (Non-clinic). She is the Deputy Director of Neuromodulation Clinic. Here research interests include individualized non-invasive brain stimulation, computational models of brain age, precise measurement of neurocognitive functions and mechanisms of cognitive ageing and resilience.